Impact of restriction of third generation cephalosporins on the burden of third generation cephalosporin resistant K. pneumoniae and E. coli in an ICU

Intensive Care Medicine

Volumn 35, Issue 5, 2009, Pages 862-870

  Meyer, Elisabeth ^a,c   Lapatschek, Matthias ^b,e   Bechtold, Andreas ^b   Schwarzkopf, Gerhard ^b   Gastmeier, Petra ^c,d   Schwab, Frank ^c,d  

^a UNIVERSITY OF FREIBURG   (Germany)

^b Munich Municipal Hospital   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d National Reference Centre for Surveillance of Nosocomial Infections   (Germany)

^e Labor Dr von Froreich   (Germany)

Author keywords

Antibiotic stewardship; Antimicrobial agents; Critical care organisation; ICU information systems

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAMASE INHIBITOR; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; IMIDAZOLE DERIVATIVE; LINCOSAMINE DERIVATIVE; METRONIDAZOLE; MEZLOCILLIN; PENICILLIN DERIVATIVE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFAMETHOXAZOLE; SULTAMICILLIN; TRIMETHOPRIM;

ABDOMINAL INFECTION; ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; BACTERIAL PERITONITIS; BACTERIAL PNEUMONIA; CATHETER INFECTION; CLINICAL PRACTICE; DEVICE INFECTION; DRUG SUBSTITUTION; DRUG USE; DRUG WITHDRAWAL; ESCHERICHIA COLI; FEMALE; GERMANY; HOSPITAL INFECTION; HOSPITAL INFORMATION SYSTEM; HUMAN; INFECTION RISK; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; REGRESSION ANALYSIS; RISK ASSESSMENT; SURGICAL WARD; TEACHING HOSPITAL; URINARY TRACT INFECTION; VENTILATOR ASSOCIATED PNEUMONIA;

BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CEPHALOSPORINS; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, MULTIPLE; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; INTENSIVE CARE; INTENSIVE CARE UNITS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; LENGTH OF STAY; MALE; MEDICATION THERAPY MANAGEMENT; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; ORGANIZATIONAL POLICY; PIPERACILLIN;

EID: 67349174542     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-008-1355-6     Document Type: Article

References (24)

1. PP Cook PG Catrou JD Christie 2004 Reduction in broad-spectrum antimicrobial use associated with no improvement in hospital antibiogram J Antimicrob Chemother 53 853 859 (Pubitemid 38660291)
2. S Nijssen M Bootsma M Bonten 2006 Potential confounding in evaluating infection-control interventions in hospital settings: changing antibiotic prescription Clin Infect Dis 43 616 623 (Pubitemid 44267124)
3. C Ramsay E Brown G Hartman 2003 Room for improvement: a systematic review of the quality of evaluations of interventions to improve hospital antibiotic prescribing J Antimicrob Chemother 52 764 771 (Pubitemid 37407802)
4. H Knothe P Shah V Krcmery 1983 Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens Infection 11 315 317 (Pubitemid 14213754)
5. H Giamarellou 2005 Multidrug resistance in gram-negative bacteria that produce extended-spectrum beta-lactamases (ESBLs) Clin Microbiol Infect 11 1 16 (Pubitemid 40946168)
6. B Du Y Long H Liu 2002 Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome Intensive Care Med 28 1718 1723 (Pubitemid 35435472)
7. C Wendt D Lin H von Baum 2005 Risk factors for colonization with third-generation cephalosporin-resistant enterobacteriaceae Infection 33 327 332 (Pubitemid 41552008)
8. JJ Rahal C Urban D Horn 1998 Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella JAMA 280 1233 1237 (Pubitemid 28469228)
9. F Ansari K Gray D Nathwani 2003 Outcomes of an intervention to improve hospital antibiotic prescribing: interrupted time series with segmented regression analysis J Antimicrob Chemother 52 842 848 (Pubitemid 37407814)
10. AK Wagner SB Soumerai F Zhang 2002 Segmented regression analysis of interrupted time series studies in medication use research J Clin Pharm Ther 27 299 309
11. C Bantar E Vesco C Heft 2004 Replacement of broad-spectrum cephalosporins by piperacillin-tazobactam: impact on sustained high rates of bacterial resistance Antimicrob Agents Chemother 48 392 395 (Pubitemid 38141693)
12. M Bassetti M Cruciani E Righi 2006 Antimicrobial use and resistance among gram-negative bacilli in an Italian intensive care unit (ICU) J Chemother 18 261 267 (Pubitemid 44098074)
13. B Du D Chen D Liu 2003 Restriction of third-generation cephalosporin use decreases infection-related mortality Crit Care Med 31 1088 1093 (Pubitemid 36444418)
14. PR Hsueh WH Chen KT Luh 2005 Relationships between antimicrobial use and antimicrobial resistance in gram-negative bacteria causing nosocomial infections from 1991 to 2003 at a university hospital in Taiwan Int J Antimicrob Agents 26 463 472 (Pubitemid 41635496)
15. CK Lan PR Hsueh WW Wong 2003 Association of antibiotic utilization measures and reduced incidence of infections with extended-spectrum beta-lactamase-producing organisms J Microbiol Immunol Infect 36 182 186 (Pubitemid 37267745)
16. E Meyer F Schwab A Pollitt 2007 Resistance rates in ICUs: interpretation and pitfalls J Hosp Infect 65 84 85
17. MJ Schwaber T De Medina Y Carmeli 2004 Epidemiological interpretation of antibiotic resistance studies-what are we missing? Nat Rev Microbiol 2 979 983 (Pubitemid 39562536)
18. DS Burgess RG Hall 2004 In vitro killing of parenteral beta-lactams against standard and high inocula of extended-spectrum beta-lactamase and non-ESBL producing Klebsiella pneumoniae Diagn Microbiol Infect Dis 49 41 46 (Pubitemid 38595625)
19. KS Thomson ES Moland 2001 Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum beta-lactamase-producing Enterobacteriaceae Antimicrob Agents Chemother 45 3548 3554 (Pubitemid 33107876)
20. P Toltzis T Yamashita L Vilt 1998 Antibiotic restriction does not alter endemic colonization with resistant gram-negative rods in a pediatric intensive care unit Crit Care Med 26 1893 1899 (Pubitemid 28527704)
21. AD Harris JC McGregor JA Johnson 2007 Risk factors for colonization with extended-spectrum beta-lactamase-producing bacteria and intensive care unit admission Emerg Infect Dis 13 1144 1149 (Pubitemid 47359156)
22. DM Livermore R Canton M Gniadkowski 2007 CTX-M: changing the face of ESBLs in Europe J Antimicrob Chemother 59 165 174 (Pubitemid 47072053)
23. JD Pitout DB Gregson DL Church 2005 Community-wide outbreaks of clonally related CTX-M-14 beta-lactamase-producing Escherichia coli strains in the Calgary health region J Clin Microbiol 43 2844 2849 (Pubitemid 40834300)
24. J Rodriguez-Bano MD Navarro L Romero 2004 Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in nonhospitalized patients J Clin Microbiol 42 1089 1094 (Pubitemid 38332830)